On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Omer Zaidi

ResearcherPublications, citations & collaboration network

Omer Zaidi is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Omer Zaidi have?

ScholarIQindexed works

Omer Zaidi has 26 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Omer Zaidi have?

ScholarIQcitation count

Omer Zaidi has 148 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Omer Zaidi?

ScholarIQh-index

Omer Zaidi has an h-index of 7 in OpenAlex.

What is the i10-index of Omer Zaidi?

ScholarIQi10-index

Omer Zaidi has an i10-index of 6 in OpenAlex.

What is the ORCID of Omer Zaidi?

ScholarIQorcid

The ORCID for Omer Zaidi is on the source record.

What is the OpenAlex record for Omer Zaidi?

ScholarIQopenalex

The OpenAlex for Omer Zaidi is on the source record.

What are the most-cited papers on Omer Zaidi?

ScholarIQmost cited works
Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction
Stephen J. Greene, Xi Tan, Yu‐Chen Yeh, Mark Bernauer, Omer Zaidi, Mei Yang, Javed Butler
Heart Failure Reviews. 202140 Citations
Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries
Omer Zaidi, Fen Du, Zhaoli Tang, Sandipan Bhattacharjee, Kristin Pareja
BMC Nephrology. 202423 CitationsOPEN ACCESS
The Real-World Incidence of Relapse in Acute Myeloid Leukemia (AML): A Systematic Literature Review (SLR)
Esther Natalie Olíva, Jacob Franek, Dipen Patel, Omer Zaidi, Salem Abi Nehme, António Almeida
Blood. 201817 Citations
Systematic literature review of the disease burden and vaccination of pneumococcal disease among adults in select Asia-Pacific areas
Terapong Tantawichien, Li Yang Hsu, Omer Zaidi, Mark Bernauer, Frieda Du, Eriko Yamada, Jin Oh Kim, Isaya Sukarom
Expert Review of Vaccines. 202113 Citations
Biosimilar pegfilgrastim may offer affordable treatment options for patients in France: a budget impact analysis on the basis of clinical trial and real-world data
Jingyan Yang, Rongzhe Liu, A. Granghaud, Omer Zaidi, Jennifer Stephens
Journal of Medical Economics. 202110 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial